Supernus Pharmaceuticals (SUPN)
(Delayed Data from NSDQ)
$28.96 USD
-1.04 (-3.47%)
Updated May 10, 2024 03:59 PM ET
After-Market: $28.95 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.38 | 0.00% |
Earnings Summary
For their last quarter, Supernus Pharmaceuticals (SUPN) reported earnings of $0.00 per share, missing the Zacks Consensus Estimate of $0.39 per share. This reflects a negative earnings surprise of 100.00%. Look out for SUPN's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.38 per share, reflecting a year-over-year increase of 2000%.
Earnings History
Price & Consensus
Zacks News for SUPN
Ahead of Supernus (SUPN) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
SUPN: What are Zacks experts saying now?
Zacks Private Portfolio Services